Imbruvica is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Imbruvica becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about GlobalPharmacyMeds.to
List of countries where we can ship Imbruvica:
Latest news releases on Imbruvica:
Find important information for patients about once-daily IMBRUVICA®. See full prescribing & safety information.
Learn about Imbruvica (Ibrutinib Capsules) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.
Imbruvica (ibrutinib) is used to treat mantle cell lymphoma and chronic lymphocytic leukemia. Includes Imbruvica side effects, interactions and indications.
IMBRUVICA® (ibrutinib) is a once-daily, oral CLL medication that can be taken with or without chemotherapy
Indications. IMBRUVICA ® (ibrutinib) is a kinase inhibitor indicated for the treatment of patients with: Mantle cell lymphoma (MCL) who have received at least one ...
Ibrutinib (Imbruvica) is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to ...
Imbruvica 140 mg hard capsules - Summary of Product Characteristics (SPC) by Janssen-Cilag Ltd
© Pharmacyclics LLC, An Abbvie Company 2016, © Janssen Biotech, Inc. 2016, CCRC-01684 06/16
IMBRUVICA ® 140 mg Hard Capsules PRESCRIBING INFORMATION ACTIVE INGREDIENT: Ibrutinib. Please refer to Summary of Product Characteristics (SmPC) before prescribing.
Enrol for You&I a no cost support programme connecting patients, who have been prescribed Imbruvica® (ibrutinib), with a nurse to answer questions